Pilar Ortiz-Vilchis

Effects of (−)-epicatechin on a diet-induced rat model of cardiometabolic risk factors

Gabriel Gutiérrez-Salmeán, Pilar Ortiz-Vilchis, Claudia Maria Vacaseydel et al. · European Journal of Pharmacology · 2014 · 82 citations

Obesity, Metabolic Syndrome, Cardiomyopathy +12

Acute effects of an oral supplement of (−)-epicatechin on postprandial fat and carbohydrate metabolism in normal and overweight subjects

Gabriela Gutiérrez-Salmeán, Pilar Ortiz-Vilchis, Claudia Maria Vacaseydel et al. · Food & Function · 2013 · 48 citations · Full text

Intravenous (−)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function

Katrina Go Yamazaki, Alexander Y. Andreyev, Pilar Ortiz-Vilchis et al. · International Journal of Cardiology · 2014 · 46 citations · Full text

Cardiovascular Disease, Mitochondrial Function, Medicine +8

The cardioprotective effects of (-)-Epicatechin are mediated through arginase activity inhibition in a murine model of ischemia/reperfusion

Pilar Ortiz-Vilchis, Miguel Ortíz-Flores, M González Pacheco et al. · European Journal of Pharmacology · 2017 · 25 citations

Inflammation, Arginase Activity Inhibition, Biochemistry +10

Arginase inhibition by (−)-Epicatechin reverses endothelial cell aging

Alejandra Garate‐Carrillo, Viridiana Navarrete-Yañez, Pilar Ortiz-Vilchis et al. · European Journal of Pharmacology · 2020 · 23 citations · Full text

Endothelial Cell Pathobiology, Endothelial Dysfunction, Cellular Senescence +7